What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Lp(a): When to Measure it and What to Do About it

Canadian Collaborative Research Network

M. O'Donoghue

Should Colchicine Become Standard Therapy for CAD?

Canadian Collaborative Research Network

P. Ridker

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

Recent Cholesterol Guidelines and Integration into Clinical Practice

The North American Thrombosis Forum (NATF)

J. Plutzky, L. Braun, J. Ross

AHA 2022: Cardiovascular Benefit of Lowering LDL Cholesterol Below 4…

AHA 2022 Conference Coverage

N. Marston

Lipids Update: Current Guidelines for Lipid Management

Scripps Health

S. R. Mehta

Intravascular Imaging Is Mandatory for Optimal PCI Outcomes: IVUS or…

San Diego Cardiovascular Interventions Symposium 2024

R. Reeves

AHA 2022: Long-Term Efficacy and Safety of Inclisiran in Patients Wi…

AHA 2022 Conference Coverage

K. Ray

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Directions of Cardiology in the Next Decade: 2022-2032

Houston Methodist DeBakey Heart and Vascular Center

E. Braunwald

How Do I Reverse Coronary Plaque?

Scripps Health

C. J. Suhar

ESC 2024 Insights: Comparison of Different Calcium Modification Stra…

ESC 2024 Insights

K. Yasumura

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

Chronic Total Occlusions: Algorithmic Approach

San Diego Cardiovascular Interventions Symposium 2024

J. Wollmuth

Cancer Before Solid Organ Transplant

Fred Hutchinson Cancer Center

C. Blosser

ACC 2022: Updates on Lowering LDL-C in Secondary Prevention - "Go as…

ACC 2022 Conference Coverage

R. Giugliano